(Q36663839)

15 August 2017

1 reference

title

Cilazapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiovascular disease (English)

1 reference

15 August 2017

1 reference

1 reference

2

Brogden RN

1 reference

15 August 2017

Deget F

1

1 reference

15 August 2017

publication date

1 May 1991

1 reference

15 August 2017

1 reference

15 August 2017

volume

41

1 reference

15 August 2017

issue

5

1 reference

15 August 2017

page(s)

799-820

1 reference

Efficacy and safety of cilazapril, a new angiotensin-converting enzyme inhibitor

15 August 2017

cites work

1 reference

12 December 2020

Lisinopril. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

1 reference

12 December 2020

The pathogenesis and prevention of aortocoronary vein bypass graft occlusion and restenosis after arterial angioplasty: role of vascular injury and platelet thrombus deposition

1 reference

12 December 2020

The effect of oral cilazapril and prazosin on the constrictor effects of locally infused angiotensin I and noradrenaline in human dorsal hand veins

1 reference

12 December 2020

Antihypertensive effects of nitrendipine and cilazapril alone, and in combination in hypertensive patients with chronic renal failure

1 reference

12 December 2020

The effects of cilazapril alone and in combination with frusemide in healthy subjects

1 reference

12 December 2020

The influence of prostaglandin inhibition by indomethacin on blood pressure and renal function in hypertensive patients treated with cilazapril

1 reference

12 December 2020

Hemodynamic responses to angiotensin I in normal volunteers and the antagonism by the angiotensin-converting enzyme inhibitor cilazapril.

1 reference

12 December 2020

Pharmacokinetics of single and consecutive doses of cilazapril and its depressor effects in patients with essential hypertension

1 reference

12 December 2020

Decreases of vascular hypertrophy in four different types of arteries in spontaneously hypertensive rats

1 reference

12 December 2020

Pharmacokinetics of the converting enzyme inhibitor cilazapril in normal volunteers and the relationship to enzyme inhibition: development of a mathematical model

1 reference

12 December 2020

Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty

1 reference

12 December 2020

The effect of acute ACE inhibition on atrial natriuretic peptide

1 reference

12 December 2020

Restenosis after successful coronary angioplasty in patients with single-vessel disease

1 reference

12 December 2020

Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells

1 reference

12 December 2020

Cilazapril inhibits vascular responses to baroreflex-stimulated sympathetic neural activity in hypertensive patients

1 reference

12 December 2020

Efficacy of cilazapril compared with hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension. Multicentre Study Group

1 reference

12 December 2020

Antihypertensive, enzymatic, and hormonal activity of cilazapril, a new angiotensin-converting enzyme inhibitor in patients with mild to moderate essential hypertension.

1 reference

12 December 2020

Inhibition of angiotensin-I response by cilazapril and its time course in normal volunteers

1 reference

12 December 2020

The influence of cilazapril on indices of autonomic function in normotensives and hypertensives

1 reference

12 December 2020

Myocardial morphology in spontaneously hypertensive and aortic-constricted rats

1 reference

12 December 2020

Interactions between cilazapril and propranolol in man; plasma drug concentrations, hormone and enzyme responses, haemodynamics, agonist dose-effect curves and baroreceptor reflex

1 reference

12 December 2020

Ramipril. A review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders

1 reference

12 December 2020

Does the combination of cilazapril and propranolol lower blood pressure at rest and during exercise more pronouncedly than either of the two components given alone?

1 reference

12 December 2020

Clinical Pharmacology of Cilazapril

1 reference

12 December 2020

Cilazapril and enalapril inhibit local angiotensin I conversion in human veins but lack direct venodilating properties

1 reference

12 December 2020

Biological properties of the angiotensin-converting enzyme inhibitor cilazapril.

1 reference

12 December 2020

Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy

1 reference

12 December 2020

Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers

1 reference

12 December 2020

Antihypertensive effects and pharmacokinetics of single and consecutive doses of cilazapril in hypertensive patients with normal and impaired renal function

1 reference

12 December 2020

The pharmacokinetics and dose proportionality of cilazapril

1 reference

12 December 2020

Efficacy and safety of cilazapril in elderly patients with essential hypertension. A multicenter study.

1 reference

12 December 2020

Cilazapril: a new non-thiol-containing angiotensin-converting enzyme inhibitor. Worldwide clinical experience in hypertension

1 reference

12 December 2020

Correlation between plasma concentration of cilazapril and haemodynamic and hormonal effects in healthy man.

1 reference

12 December 2020

Glucose and Lipid Metabolism During Long-Term Treatment with Cilazapril in Hypertensive Patients With or Without Impaired Glucose Metabolism

1 reference

12 December 2020

[Cilazapril in essential hypertension. A placebo-controlled double-blind study to establish the dosage]

1 reference

12 December 2020

Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study

1 reference

12 December 2020

A method for estimating the potency of angiotensin-converting enzyme inhibitors in man.

1 reference

12 December 2020

Effects of cilazapril on renal function and hormones in hypertensive patients with renal disease.

1 reference

12 December 2020

A pharmacokinetic study of cilazapril in elderly and young volunteers

1 reference

12 December 2020

Effects of chronic heart failure on the responsiveness to angiotensin I and to angiotensin converting enzyme inhibition with cilazapril in rats

1 reference

12 December 2020

Recurrence rate after successful coronary angioplasty

1 reference

12 December 2020

Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty

1 reference

12 December 2020

Prevalence of cough during angiotensin-converting enzyme inhibitor therapy

1 reference

12 December 2020

Efficacy and safety of cilazapril in hypertensive patients with moderate to severe renal impairment.

1 reference

12 December 2020

Pharmacokinetics and effects on renal function following cilazapril and hydrochlorothiazide alone and in combination in healthy subjects and hypertensive patients

1 reference

12 December 2020

Vascular angiotensin converting enzyme activity in spontaneously hypertensive rats and its inhibition with cilazapril

1 reference

12 December 2020

Enzyme immunoassay discrimination of a new angiotensin-converting enzyme (ACE) inhibitor, cilazapril, and its active metabolite

1 reference

12 December 2020

A review of the preclinical cardiovascular pharmacology of cilazapril, a new angiotensin converting enzyme inhibitor

1 reference

12 December 2020

The pharmacokinetics and angiotensin converting enzyme inhibition dynamics of cilazapril in essential hypertension

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors. Relationship between pharmacodynamics and pharmacokinetics

1 reference

12 December 2020

ACE Inhibition with Cilazapril Improves Myocardial Perfusion to the Ischemic Regions During Exercise

1 reference

12 December 2020

Cilazapril prevents hypertension in spontaneously hypertensive rats

1 reference

12 December 2020

Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA registry of the national heart, lung, and blood institute

1 reference

12 December 2020

Pharmacokinetics of single and consecutive doses of cilazapril and its depressor effects in hypertensive patients with renal dysfunction

1 reference

12 December 2020

Physiological aspects of primary hypertension

1 reference

12 December 2020

Cilazapril in congestive heart failure. A pilot study

1 reference

12 December 2020

Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids

1 reference

12 December 2020

Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

1 reference

12 December 2020

Effects of cilazapril on the cerebral circulation in spontaneously hypertensive rats.

1 reference

12 December 2020

A pharmacokinetic study of cilazapril in patients with congestive heart failure

1 reference

12 December 2020

Antihypertensive treatment with cilazapril. Resting and exercise blood pressure, hormones and enzymes

1 reference

12 December 2020

The influence of food on the pharmacokinetics and ACE inhibition of cilazapril

1 reference

12 December 2020

The pharmacokinetics and bioavailability of cilazapril in normal man.

1 reference

12 December 2020

Relative inhibitory potency and plasma drug levels of angiotensin converting enzyme inhibitors in the rat

1 reference

12 December 2020

Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury

1 reference

12 December 2020

Influence of the angiotensin converting enzyme inhibitor cilazapril, the beta-blocker propranolol and their combination on haemodynamics in hypertension

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic interactions between the ACE inhibitor cilazapril and beta-adrenoceptor antagonist propranolol in healthy subjects and in hypertensive patients

1 reference

12 December 2020

Effects of acute and chronic cilazapril treatment in spontaneously hypertensive rats

1 reference

12 December 2020

The effect of cilazapril on systolic and diastolic cardiac function in hypertensive patients

1 reference

12 December 2020

Vascular Protection with Cilazapril

1 reference

12 December 2020

Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial

1 reference

12 December 2020

[Cilazapril in essential hypertension. A study of one year of continuous treatment]

1 reference

12 December 2020

The renin-angiotensin system: systemic and local function

1 reference

12 December 2020

A single dose of cilazapril improves diastolic function in hypertensive patients

1 reference

12 December 2020

Effects of single doses of the converting enzyme inhibitor cilazapril in normal volunteers

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition versus blockade of the renin-angiotensin system

1 reference

12 December 2020

Acute Effects of the New Angiotensin-Converting Enzyme Inhibitor Cilazapril: A Pilot Study

1 reference

12 December 2020

The assessment of ACE activity in man following angiotensin I challenges: a comparison of cilazapril, captopril and enalapril

1 reference

12 December 2020

Cardiovascular effects of the new angiotensin-converting-enzyme inhibitor, cilazapril, in anesthetized and conscious dogs

1 reference

12 December 2020

The 24 h blood pressure responses of hypertensives to a once-a-day cilazapril regimen

1 reference

12 December 2020

Cough caused by cilazapril

1 reference

12 December 2020

The pharmacodynamics and dose-response relationships of the angiotensin converting enzyme inhibitor, cilazapril, in essential hypertension

1 reference

12 December 2020

Long-term evaluation of cilazapril in severe hypertension. Assessment of left ventricular and renal function.

1 reference

12 December 2020

10.2165/00003495-199141050-00008

Identifiers

DOI

1 reference

Dimensions Publication ID

15 August 2017

1018204336

0 references

1 reference